Cancer Types

Myeloma

Treatment Is Waiting

For patients with chronic blood cancers, the early intervention mantra of cancer does not always apply.

by Sue Rochman
Yesterday & Today

Taking Her Place

Geraldine Ferraro, the first woman nominated for vice president on a major-party ticket, used her political prowess to advocate for women's equality. In 1998, she was diagnosed with multiple myeloma.

by Sharlene George
Forward Look

African-Americans at Higher Risk for Multiple Myeloma

Researchers aim to identify possible reasons.

by Sue Rochman

Forward Look

Paying a Steep Price

New laws are pushing health insurers to make oral cancer drugs affordable.

by Betty Russell

Previous |

Cancer Talk

Declining Breast Cancer Mortality in Younger Women

U.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.

by Kevin McLaughlin

Missed Activities Due to Cancer-related Fatigue and Depression

Women were more likely than men to have fatigue or depression linked to cancer, and both effects were linked to people withdrawing from physical activities.

by Eric Fitzsimmons

Immunotherapy Improves Results in Head and Neck Cancer

Combining an immune checkpoint inhibitor with standard care extended event-free survival by nearly two years.

by Thomas Celona

Federal Support for Cancer Research Takes the Stage at AACR Annual Meeting

Scientists and former administrators gather for session focused on advocating for cancer research in uncertain times.

by Kevin McLaughlin

From the AACR

Inaugural AACR IO Conference Kicks Off With Celebration of Immune Checkpoints

Immune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
A New Resource Provides a Sanctuary for Black TNBC Patients

The Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.

Video

Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial